COVID-19: consider cytokine storm syndrome and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., Manson, J. J., & HLH Across Speciality Collaboration, UK (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England), 395(10229), 1033–1034. https://doi.org/10.1016/S0140-6736(20)30628-0
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Neurological Associations of COVID-19
Endothelial cell infection and endotheliitis in COVID-19
Clinical impact of COVID-19 on patients with cancer
Hyperinflammatory shock in children during the COVID-19 pandemic
COVID-19 Cytokine Storm: the interplay between inflammation and coagulation
COVID-19: consider cytokine storm syndrome and immunosuppression
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Canakinumab in a subgroup of patients with COVID-19
Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Human recombinant soluble ACE2 in severe COVID-19
Association between high serum total cortisol concentrations and mortality from COVID-19